FRISCO, Texas and SYDNEY, March 14, 2013 (GLOBE NEWSWIRE) -- OxySure(R) Systems, Inc. (OTCQB:OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that it has retained MZ Group as its investor relations advisor in Australia, Brazil and the U.S.
MZ Group will assist OxySure with communicating its corporate, financial and investor-related developments to shareholders and investors, as well as expanding its shareholder base, particularly in North America.
Julian Ross, Chief Executive Officer of OxySure, explained, "This is an ideal time for us to increase our investor outreach. Our flagship product, OxySure Model 615, the only over the counter device in the U.S. cleared by the FDA for emergency respiratory applications, recently saved its 2,000thlife. Having signed several new distribution agreements over the past six months and expanding our sales capability, we see an inflection point in our revenues on the horizon."
Ted Haberfield, President of MZ Group North America, stated, "We are extremely impressed with OxySure's business model and growth opportunities. As the only U.S. FDA approved product based on proprietary technologies, the value proposition is extremely compelling. Once they are able to expand their installed base of systems across schools, restaurants and offices, they have a tremendous opportunity to generate significant recurring cash flows. We look forward to introducing their story to retail and institutional investors."
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
About MZ Group
MZ Group, subsidiary of @titude Global, a multinational company and the world's largest independent global investor relations consulting firm, provides investor relations, corporate communications, market intelligence, corporate governance and technology products and services. Founded in 1999, MZ Group focuses on innovation and personalized services, supported by its exclusive "one-stop-shop" business model. With offices in São Paulo, New York, Chicago, San Diego, Vancouver, Hong Kong, Beijing, Shanghai, Taipei and Mumbai, MZ has approximately 350 professionals who serve over 580 clients in 12 countries. For more information, please visit www.mzgroup.com.
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
This information was brought to you by Cision http://news.cision.com
Source:OxySure Systems, Inc.